
Department: MRQ
Location: Bangalore - India
As Associate Director – Cardiometabolic Medical, you will lead the Medical Affairs and Medical Education strategic plans for your affiliate in International Operations – and make sure they deliver. You will turn medical strategy into action, from medical events and local clinical trials to publications and new product launches, keeping medical and marketing aligned. Your scientific leadership will help bring credible evidence and education to the healthcare professionals who support people living with cardiometabolic diseases.
You are a medical doctor with deep industry experience, ready to lead medical strategy and act as the scientific voice of the affiliate.
You will own the delivery of medical strategy for the affiliate, making sure it is aligned with International Operations priorities and the scientific needs of the business.
You will join the Cardiometabolic Medical team in India, where colleagues work across markets to serve people around the world and help improve health at scale.
Around 80% of your interactions will be with internal colleagues. You will contribute to functional team meetings and work closely with marketing and other functions to align plans, share best practices and influence tactical decisions. You will approach colleagues across functions for input on projects, using a working-group approach that keeps work moving with clarity and speed.
The remaining 20% will be with external stakeholders, as you deliver medical education, local studies and scientific communication.
You will have the scope to shape medical strategy and see it come to life in the affiliate. Your ideas are welcome: you will be encouraged to put forward new approaches, share best practice and speak up. Once a decision is made, we commit and move forward together.
As priorities change at corporate and management level, you will help your colleagues understand what this means and adapt with them. This is a role for someone who learns from the world outside Novo, raises the bar every day and never compromises on quality, ethics or patient safety. You will grow with colleagues on the job, through cross-functional collaboration and relevant learning offerings.
Your impact begins today. If you are ready to lead medical strategy that brings evidence and education to people across International Operations, apply for the Associate Director – Cardiometabolic Medical role by 31 October 2026.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health.
Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com.
This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html